Moderna advances messenger RNA platform technologies Therapeutics pipeline spans vaccines and disease targets nasdaq index ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine skepticism rises, according to Moderna (MRNA) co-founder and chairman Noubar ...

The FDA has refused to consider Moderna's application for a new flu vaccine using mRNA technology, criticizing the design of its clinical trial. Despite the agency's concerns, Moderna argues there are ...

This new filing is not an isolated event but represents another front in a protracted legal war between the two biotech firms. The conflict has a precedent: Moderna originally sued both BioNTech and ...

Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines for infectious diseases. The ...

Timing and eligibility for the COVID-19 public vaccination program in Canada is set by each province and territory. Those who meet provincial criteria will receive COVID-19 vaccines free of charge.

Shares of Moderna MRNA rose 13% in the past week after the company announced preliminary sales for the full-year 2025, as well as business outlook for 2026 and beyond. It also outlined some expected ...